Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 1, 2022
Distillery Therapeutics

CDH17-targeting CAR T cells for solid tumors

BioCentury | May 22, 2021
Product Development

New paths for a bispecific road less traveled 

Bispecific antibodies targeting two tumor antigens are picking up steam, and their benefits could extend to ADCs
Items per page:
1 - 2 of 2